Press

Insights

Contact Us

iPlato, a Huma company – home
News

/

A Year to Remember: Reflecting on 2024 at iPLATO

Huma Intelligence & Selfbook: patient communication as you’ve never experienced before

December 16, 2024

A Year to Remember: Reflecting on 2024 at iPLATO

By Tobias Alpsten, CEO and Founder of iPLATO 

As 2024 comes to a close, I’ve been reflecting on what has been an extraordinary year for iPLATO. It’s been a year of milestones, growth, and partnerships that have taken us closer to our mission of improving healthcare access and outcomes for millions across the UK. This journey has been filled with proud moments, and I’m excited to share some of them with you.

The most significant step we’ve taken this year was joining forces with eConsult. In October this year, Huma acquired eConsult, a market leader within the digital triage and online consultation space in the UK.Together, we’ve combined iPLATO’s patient communication platform and eConsult’s online triage expertise to create a stronger, more integrated solution for healthcare providers.

What makes this so exciting is the potential we now have to serve over 50 million patients across the UK. We offered every iPLATO GP practice in England access to the iPLATO Toolbar for free, streamlining their patient communications and making it easier to provide timely care. At the same time, eConsult users are benefiting from tools like Selfbook, Connect, Patient Questionnaires and more! iPLATO users can now access eConsult’s structured online consultations.

This merger isn’t just about technology; it’s about the people. By bringing together our expertise, we’re making it easier for practices to offer high-quality care in a way that is accessible, efficient, and cost-effective.

Another highlight of 2024 has been the recognition we’ve received for our work. Winning the Best Virtual Care Project at the HTN Now Awards alongside Huma was a proud moment. The award was for our GDm-Health solution, which helps pregnant women with gestational diabetes manage their condition and enables clinicians to monitor them remotely. It’s a fantastic example of how digital tools can transform healthcare for both patients and providers.

We were also thrilled to be finalists in the British Data Awards, recognised for our efforts in tackling health inequalities. By analysing NHS data and deprivation indices, we’ve helped identify gaps in care and supported better resource allocation. This work is about making sure every patient gets the care they need, regardless of where they live or their circumstances.

We’ve also made great strides in building partnerships that bring tangible benefits to patients and practices. One of the most exciting moments was securing our contract with Wales, where we’ll be providing patient communications for all GP practices. This means practices across the country will have access to tools like the iPLATO Toolbar, enabling them to save time, improve communication, and focus on patient care.

Another important partnership was with Greater Manchester Cancer Alliance to promote the Targeted Lung Health Check programme. By using our Population Health service, we’re encouraging more people to participate in life-saving lung cancer screenings. It’s initiatives like this that remind me why we do what we do—to make a real difference in people’s lives.

We’ve also continued to support regions like Kent and Medway, Lancashire and South Cumbria, and Cambridge and Peterborough with tailored solutions that improve efficiency and free up valuable resources for frontline care.

Three practices in North Central London have reached a remarkable milestone, using our platform for an incredible 20 years! Clerkenwell Medical Practice, City Road Medical Centre, and The Goodinge Group Practice all onboarded in August 2004 and remain valued users of the platform to this day. We extend our gratitude to these practices for their ongoing support and trust in our digital solutions over the years. Here’s to continuing our partnership and driving even more innovation in healthcare together! 

Our Population Health service is making strides in public health programmes, our most notable being BEST4 bowel cancer screening. iPLATO plays a pivotal role in partnering with the NHS to drive earlier identification of bowel cancer through innovative digital solutions. Recognising that bowel cancer accounts for 11% of all new cancer cases in the UK, iPLATO focuses on increasing screening uptake among underserved populations, breaking down barriers such as language, stigma, and socio-economic challenges. By delivering targeted SMS reminder programmes and leveraging Digital Patient Questionnaires — achieving completion rates of up to 42% — iPLATO has successfully increased bowel cancer screening uptake by 16%. These efforts help normalise screening within communities, promote education, and support earlier detection at stages 1-2, improving health outcomes while reducing treatment costs.

This year, we celebrated reaching three million users on the myGP app—a milestone that reflects how far we’ve come in empowering people to manage their health. Our app has become a vital tool for booking appointments, managing repeat prescriptions, and even checking blood pressure and skin health from the comfort of home.

In 2024 alone, myGP users booked over 1.1 million appointments and placed more than 12 million repeat prescription orders. We’ve also helped practices reclaim thousands of hours by managing cancellations more efficiently, freeing up time for patients who need it most.

Together with our pharmacy partners – LloydsDirect, Pharmacy2U, PillTime and Phlo – we simplified access to prescription medication through digital first. We also added tools to improve adherence and persistence to prescribed medication.

iPLATO’s partnership with Healthera’s national pharmacy network to enhance the myGP app with advanced Click-and-Collect prescription services and access to bookable pharmacy services, including flu and COVID-19 vaccinations and treatment for common conditions has been hugely successful. Through this partnership, myGP users can now seamlessly book vaccinations and manage prescriptions across over 1,500 local pharmacies in Healthera’s growing network. This integration not only simplifies access to essential healthcare services but also strengthens patient engagement with their local community pharmacies.

With over 30 million people eligible for free flu vaccines and NHS initiatives like Pharmacy First expanding access to care for seven common conditions, iPLATO and Healthera’s collaboration empowers patients to prioritise their health with ease.

Our innovations, like the Autoderm skin checker and Lifelight’s blood pressure checker, are helping people take control of their health in ways that are simple, effective, and accessible. It’s a privilege to see these tools making such a positive impact.

As we head into 2025, I’m more optimistic than ever about what we can achieve. Thank you to everyone who has been part of this journey—our partners, our team, and the millions of patients who trust us to help them manage their health. 

Here’s to 2025!

Tobias

Press

Insights

Contact Us

iPlato, a Huma company – home

Practice Area

News

/

A Year to Remember: Reflecting on 2024 at iPLATO

Huma Intelligence & Selfbook: patient communication as you’ve never experienced before

December 16, 2024

A Year to Remember: Reflecting on 2024 at iPLATO

By Tobias Alpsten, CEO and Founder of iPLATO 

As 2024 comes to a close, I’ve been reflecting on what has been an extraordinary year for iPLATO. It’s been a year of milestones, growth, and partnerships that have taken us closer to our mission of improving healthcare access and outcomes for millions across the UK. This journey has been filled with proud moments, and I’m excited to share some of them with you.

The most significant step we’ve taken this year was joining forces with eConsult. In October this year, Huma acquired eConsult, a market leader within the digital triage and online consultation space in the UK.Together, we’ve combined iPLATO’s patient communication platform and eConsult’s online triage expertise to create a stronger, more integrated solution for healthcare providers.

What makes this so exciting is the potential we now have to serve over 50 million patients across the UK. We offered every iPLATO GP practice in England access to the iPLATO Toolbar for free, streamlining their patient communications and making it easier to provide timely care. At the same time, eConsult users are benefiting from tools like Selfbook, Connect, Patient Questionnaires and more! iPLATO users can now access eConsult’s structured online consultations.

This merger isn’t just about technology; it’s about the people. By bringing together our expertise, we’re making it easier for practices to offer high-quality care in a way that is accessible, efficient, and cost-effective.

Another highlight of 2024 has been the recognition we’ve received for our work. Winning the Best Virtual Care Project at the HTN Now Awards alongside Huma was a proud moment. The award was for our GDm-Health solution, which helps pregnant women with gestational diabetes manage their condition and enables clinicians to monitor them remotely. It’s a fantastic example of how digital tools can transform healthcare for both patients and providers.

We were also thrilled to be finalists in the British Data Awards, recognised for our efforts in tackling health inequalities. By analysing NHS data and deprivation indices, we’ve helped identify gaps in care and supported better resource allocation. This work is about making sure every patient gets the care they need, regardless of where they live or their circumstances.

We’ve also made great strides in building partnerships that bring tangible benefits to patients and practices. One of the most exciting moments was securing our contract with Wales, where we’ll be providing patient communications for all GP practices. This means practices across the country will have access to tools like the iPLATO Toolbar, enabling them to save time, improve communication, and focus on patient care.

Another important partnership was with Greater Manchester Cancer Alliance to promote the Targeted Lung Health Check programme. By using our Population Health service, we’re encouraging more people to participate in life-saving lung cancer screenings. It’s initiatives like this that remind me why we do what we do—to make a real difference in people’s lives.

We’ve also continued to support regions like Kent and Medway, Lancashire and South Cumbria, and Cambridge and Peterborough with tailored solutions that improve efficiency and free up valuable resources for frontline care.

Three practices in North Central London have reached a remarkable milestone, using our platform for an incredible 20 years! Clerkenwell Medical Practice, City Road Medical Centre, and The Goodinge Group Practice all onboarded in August 2004 and remain valued users of the platform to this day. We extend our gratitude to these practices for their ongoing support and trust in our digital solutions over the years. Here’s to continuing our partnership and driving even more innovation in healthcare together! 

Our Population Health service is making strides in public health programmes, our most notable being BEST4 bowel cancer screening. iPLATO plays a pivotal role in partnering with the NHS to drive earlier identification of bowel cancer through innovative digital solutions. Recognising that bowel cancer accounts for 11% of all new cancer cases in the UK, iPLATO focuses on increasing screening uptake among underserved populations, breaking down barriers such as language, stigma, and socio-economic challenges. By delivering targeted SMS reminder programmes and leveraging Digital Patient Questionnaires — achieving completion rates of up to 42% — iPLATO has successfully increased bowel cancer screening uptake by 16%. These efforts help normalise screening within communities, promote education, and support earlier detection at stages 1-2, improving health outcomes while reducing treatment costs.

This year, we celebrated reaching three million users on the myGP app—a milestone that reflects how far we’ve come in empowering people to manage their health. Our app has become a vital tool for booking appointments, managing repeat prescriptions, and even checking blood pressure and skin health from the comfort of home.

In 2024 alone, myGP users booked over 1.1 million appointments and placed more than 12 million repeat prescription orders. We’ve also helped practices reclaim thousands of hours by managing cancellations more efficiently, freeing up time for patients who need it most.

Together with our pharmacy partners – LloydsDirect, Pharmacy2U, PillTime and Phlo – we simplified access to prescription medication through digital first. We also added tools to improve adherence and persistence to prescribed medication.

iPLATO’s partnership with Healthera’s national pharmacy network to enhance the myGP app with advanced Click-and-Collect prescription services and access to bookable pharmacy services, including flu and COVID-19 vaccinations and treatment for common conditions has been hugely successful. Through this partnership, myGP users can now seamlessly book vaccinations and manage prescriptions across over 1,500 local pharmacies in Healthera’s growing network. This integration not only simplifies access to essential healthcare services but also strengthens patient engagement with their local community pharmacies.

With over 30 million people eligible for free flu vaccines and NHS initiatives like Pharmacy First expanding access to care for seven common conditions, iPLATO and Healthera’s collaboration empowers patients to prioritise their health with ease.

Our innovations, like the Autoderm skin checker and Lifelight’s blood pressure checker, are helping people take control of their health in ways that are simple, effective, and accessible. It’s a privilege to see these tools making such a positive impact.

As we head into 2025, I’m more optimistic than ever about what we can achieve. Thank you to everyone who has been part of this journey—our partners, our team, and the millions of patients who trust us to help them manage their health. 

Here’s to 2025!

Tobias

Press

Insights

Contact Us

News

/

Huma Intelligence & Selfbook: patient communication as you’ve never experienced before

Huma Intelligence & Selfbook: patient communication as you’ve never experienced before

December 16, 2024

By Adam Faucheux, Field CEO at iPLATO.

This month, we were delighted to launch our newest innovative feature, Huma Intelligence, an AI powered message improver, along with the latest version of Selfbook. As digital tools continue to reshape healthcare, our commitment at iPLATO is to build solutions that empower practices, support patients, and drive efficiency.

Huma Intelligence: where AI meets healthcare 

Huma Intelligence is already changing the healthcare game. In this application within Huma Workspace for Primary Care, it delivers improvements to the quality of language used in patient messaging while simultaneously reducing SMS costs. 

In healthcare, clarity and brevity are crucial, but achieving both can be challenging in patient communication. Initial trials indicate a 20% reduction in SMS costs, allowing GPs, PCNs and ICBs to optimise their budgets without compromising message quality.

The use of AI in healthcare communications is not just about cost-saving—it’s also about enhancing understanding and adherence. Studies, such as those from the National Institutes of Health, highlight that clear, concise communication leads to better patient outcomes and fewer missed appointments. Huma Intelligence is set to have a reading age of 9-11 years, which is inline with the NHS Digital Service Manual. AI’s ability to refine language and ensure messages are tailored to patient comprehension levels is a step forward in improving health literacy and engagement.



Our work at iPLATO, and across the Primary Care space within Huma Workspace, reflects our fundamental belief in the transformative role that AI can play—not as a replacement for human expertise, but as a powerful tool that supports practitioners and enhances patient experiences. I’m excited to see the ways in which Huma Intelligence will help practices communicate more effectively and drive patient engagement, while keeping costs down. 

Selfbook: Leading the way in digital patient engagement

With Selfbook, we’ve created a tool designed to simplify the booking process while providing practices with robust management capabilities. This release includes several key features that enhance Selfbook’s utility and position it as a leader in the field, especially against competitors like AccuRx.

Our unique advantages:

Campaign reach—up to 100,000 patients: Scaling outreach is critical, especially in high-demand campaigns. Selfbook’s capacity to import and manage up to 100,000 patients in a single campaign is an industry game-changer, allowing practices to engage large groups swiftly and efficiently.

Integrated questionnaires with booking link: We know that patient engagement is more than just scheduling. Imagine having all the key patient information you need before they even step through the door. With this new update, you don’t have to imagine! Practices can include customised, integrated questionnaires directly with the booking link. This seamless combination means GPs can spend less time gathering data and more time providing patient care. 

Valuable insights: Users will now have the ability to measure campaign statistics and monitor how their patients use Selfbook. This makes it incredibly easy for practices to keep on top of their patients and follow up when necessary. Lastly, users now have the flexibility to correct any mistakes in their campaign and even extend it if the statistics indicate low engagement or uptake.

Here’s what the campaign statistics can measure: 

  • Success Rate: The percentage of invited patients who successfully booked their appointment online using iPLATO Selfbook.
  • Booking Timeline: Dates on which appointments were booked.
  • “Booked” Table: A list of patients who have booked appointments, along with their selected slot times.
  • “Not Booked” Table: A list of patients who have not yet booked an appointment using iPLATO Selfbook (note: they may have booked via other means). You can export this data to create a targeted reminder or follow-up campaign.

 

NHS App compatibility: As more patients turn to the NHS App, integration becomes essential. Selfbook’s compatibility allows patients to book appointments and complete health questionnaires without switching platforms, providing a streamlined experience that aligns with their regular app usage. Another benefit is that this integration allows practices to save on SMS costs. 

I look forward to seeing how these solutions will deliver value to the NHS across our 2025 roadmap and beyond. If you have any questions about the above features, please reach out to us at sales@iplato.com.